Bausch Health Companies Inc. valuation and forecast
Explore the models for Bausch Health Companies Inc., adjust their assumptions and compare your own valuation with the platform's.
Stock price today
Loading chart…
Third-party market data · may be delayed
Fair value per share
Under review: every model's value for Bausch Health Companies Inc. is far from the share price, which usually points to a data problem (a merger, a share-count change, a one-off) rather than a bargain or a bubble.
Price vs value
Under review: our cash-flow value ($107.04) was left out of our combined valuation (it is 13.31x the share price, outside the 0.2-5x range we accept), so it can't be the basis of a rating. We'll show the comparison once resolved.
Your valuation workspace
What is BHC worth to you?
Start with the company's financial data. Make the assumptions your own.
01 / Assumptions
Follow the forecast
The cash flows behind your value
View annual figures
| Forecast year | Cash flow / share |
|---|
Negative cash flows are shown in terracotta. Before the terminal value and equity bridge. Residual-income models show excess earnings; dividend models show dividends.
See the range of possibilities
Compare and combine your models
Weights start with the platform's included models. Change them to build your own combination. Select a model name to edit its assumptions.
| Model | Your value / share | Weight |
|---|
The platform's price and consistency filters are not reapplied to your scenarios.
Other model types 20 unavailable for BHC
Residual income
This model is withheld pending its input or assumption review.
Justified price-to-book
This model is withheld pending its input or assumption review.
Revenue-to-maturity DCF
This model does not apply to this company with the available financial data.
Growth DCF
This model does not apply to this company with the available financial data.
P/B vs return on equity
This model does not apply to this company with the available financial data.
Peer price-to-book
This model does not apply to this company with the available financial data.
Peer P/E
This model does not apply to this company with the available financial data.
Peer price-to-FFO
This model does not apply to this company with the available financial data.
Peer price-to-sales
This model does not apply to this company with the available financial data.
Forward peer price-to-sales
This model does not apply to this company with the available financial data.
P/E comparison
This model does not apply to this company with the available financial data.
P/S comparison
This model does not apply to this company with the available financial data.
PEG comparison
This model does not apply to this company with the available financial data.
Two-stage dividend discount
This model does not apply to this company with the available financial data.
Growing-dividend model
This model does not apply to this company with the available financial data.
REIT funds from operations
This model does not apply to this company with the available financial data.
Utility earnings
This model does not apply to this company with the available financial data.
Book value / net assets
This model does not apply to this company with the available financial data.
Reported crypto treasury NAV
This model does not apply to this company with the available financial data.
Proved-reserve NAV
This model does not apply to this company with the available financial data.
Model values are estimates under the assumptions shown. They are not share-price forecasts or investment advice.
Valuation models compared
Different models answer different questions: the cash-flow models ask what the business generates for owners; the peer multiples ask what similar companies in our coverage trade on. Where they disagree, the gap is the story. Projections are estimates based on current data, updated daily. Not investment advice. How each model works.
Analyst recommendations
Monthly trend
- Oct 20267
- Sep 20267
- Aug 20267
- Jul 20267
Counts of recommendations published by analysts covering Bausch Health Companies Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.
Price history
Loading chart…
Third-party market data · may be delayed
The assumptions
- Free cash flow (TTM, FY2026 Q3)
- $1.9B
- Less stock-based pay
- $242M
- Cash flow we value
- $2.6B
- Growth, years 1–5 (base)
- %
- Then fading to
- 2.5%
- Discount rate
- 8.5%
- Net cash added
- -$19.1B
- Diluted shares
- 374M
What would move the value
- Growth 5 points lower
- −32%
- Growth 5 points higher
- +41%
- Free-cash-flow margin 1 point lower
- −5%
- Discount rate 1 point higher
- −20%
Change in our model value when one input moves, all else equal.
BHC valuation questions
- How does Fundamentalytics value Bausch Health Companies Inc.?
- We use the models that fit Bausch Health Companies Inc.'s business and available financial data. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.
Data: SEC EDGAR filings, retrieved October 31, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Bausch Health Companies Inc.